Get started
WEST PHARM.SVCS DL-,25WEST PHARM.SVCS DL-,25WEST PHARM.SVCS DL-,25

WEST PHARM.SVCS DL-,25

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

WPS chart


Full chart

WPS upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪21.16 B‬ EUR
Dividend yield (indicated)
0.27%
Price to earnings Ratio (TTM)
45.2
Basic EPS (TTM)
6.1 EUR
Net income (FY)
‪537.63 M‬ EUR
Revenue (FY)
‪2.67 B‬ EUR
Shares float
‪72.00 M‬
Beta (1Y)
0.78

Employees


Employees (FY)
‪10.6 K‬
Change (1Y)
−100 −0.93%
Revenue / Employee (1Y)
‪278.41 K‬ EUR
Net income / Employee (1Y)
‪55.98 K‬ EUR

About West Pharmaceutical Services, Inc.


Sector
Health Technology
Industry
Medical Specialties
CEO
Eric Mark Green
Website
westpharma.com
Headquarters
Exton
Founded
1923
FIGI
BBG000JL73P1
West Pharmaceutical Services, Inc. manufactures and markets pharmaceuticals, biologics, vaccines and consumer healthcare products. It operates through the following business segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers proprietary packaging, containment and drug delivery products, along with analytical lab services, to biologic, generic and pharmaceutical drug customers. The Contract-Manufactured Products segment serves as a fully integrated business, focused on the design, manufacture and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. The company was founded by Herman O. West on July 27, 1923 and is headquartered in Exton, PA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

WPS news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of WPS is 288.8 EUR — it has increased by 2.70% in the past 24 hours. Watch WEST PHARM.SVCS DL-,25 stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange WEST PHARM.SVCS DL-,25 stocks are traded under the ticker WPS.
WPS stock has risen by 1.80% compared to the previous week, the month change is a 7.96% rise, over the last year WEST PHARM.SVCS DL-,25 has showed a −5.59% decrease.
We've gathered analysts' opinions on WEST PHARM.SVCS DL-,25 future price: according to them, WPS price has a max estimate of 435.47 EUR and a min estimate of 245.53 EUR. Watch WPS chart and read a more detailed WEST PHARM.SVCS DL-,25 stock forecast: see what analysts think of WEST PHARM.SVCS DL-,25 and suggest that you do with its stocks.
WPS reached its all-time high on Jan 3, 2022 with the price of 420.2 EUR, and its all-time low was 12.1 EUR and was reached on Oct 5, 2010. View more price dynamics on WPS chart.
See other stocks reaching their highest and lowest prices.
WPS stock is 2.63% volatile and has beta coefficient of 0.78. Track WEST PHARM.SVCS DL-,25 stock price on the chart and check out the list of the most volatile stocks — is WEST PHARM.SVCS DL-,25 there?
Today WEST PHARM.SVCS DL-,25 has the market capitalization of ‪20.96 B‬, it has decreased by −5.60% over the last week.
Yes, you can track WEST PHARM.SVCS DL-,25 financials in yearly and quarterly reports right on TradingView.
WEST PHARM.SVCS DL-,25 is going to release the next earnings report on Feb 13, 2025. Keep track of upcoming events with our Earnings Calendar.
WPS earnings for the last quarter are 1.66 EUR per share, whereas the estimation was 1.35 EUR resulting in a 23.27% surprise. The estimated earnings for the next quarter are 1.58 EUR per share. See more details about WEST PHARM.SVCS DL-,25 earnings.
WEST PHARM.SVCS DL-,25 revenue for the last quarter amounts to ‪670.82 M‬ EUR, despite the estimated figure of ‪637.34 M‬ EUR. In the next quarter, revenue is expected to reach ‪680.42 M‬ EUR.
WPS net income for the last quarter is ‪122.15 M‬ EUR, while the quarter before that showed ‪103.91 M‬ EUR of net income which accounts for 17.55% change. Track more WEST PHARM.SVCS DL-,25 financial stats to get the full picture.
Yes, WPS dividends are paid quarterly. The last dividend per share was 0.18 EUR. As of today, Dividend Yield (TTM)% is 0.25%. Tracking WEST PHARM.SVCS DL-,25 dividends might help you take more informed decisions.
WEST PHARM.SVCS DL-,25 dividend yield was 0.22% in 2023, and payout ratio reached 9.90%. The year before the numbers were 0.31% and 9.57% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 5, 2024, the company has ‪10.60 K‬ employees. See our rating of the largest employees — is WEST PHARM.SVCS DL-,25 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. WEST PHARM.SVCS DL-,25 EBITDA is ‪670.73 M‬ EUR, and current EBITDA margin is 28.74%. See more stats in WEST PHARM.SVCS DL-,25 financial statements.
Like other stocks, WPS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade WEST PHARM.SVCS DL-,25 stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So WEST PHARM.SVCS DL-,25 technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating WEST PHARM.SVCS DL-,25 stock shows the sell signal. See more of WEST PHARM.SVCS DL-,25 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.